Advanced search
Publication Cover
Pain Management Volume 4, 2014 - Issue 2
Submit an article Journal homepage
71
Views
0
CrossRef citations to date
0
Altmetric
Review

Multipotent Stromal Cells for Arthritic Joint Pain Therapy and Beyond

Wei Guo1 Department of Neural & Pain Sciences, School of Dentistry, University of Maryland, Baltimore, MD21201, USA;2 Program in Neuroscience, University of Maryland, Baltimore, MD21201, USAView further author information
,
Satoshi Imai1 Department of Neural & Pain Sciences, School of Dentistry, University of Maryland, Baltimore, MD21201, USA;2 Program in Neuroscience, University of Maryland, Baltimore, MD21201, USAView further author information
,
Ronald Dubner1 Department of Neural & Pain Sciences, School of Dentistry, University of Maryland, Baltimore, MD21201, USA;2 Program in Neuroscience, University of Maryland, Baltimore, MD21201, USAView further author information
&
Ke Ren2 Program in Neuroscience, University of Maryland, Baltimore, MD21201, USA;1 Department of Neural & Pain Sciences, School of Dentistry, University of Maryland, Baltimore, MD21201, USACorrespondence[email protected]
View further author information
Pages 153-162 | Published online: 05 Mar 2014

References

  • Zhang RX , RenK, DubnerR. Osteoarthritis pain mechanisms: basic studies in animal models. Osteoarthritis Cartilage21(9) , 1308–1315 (2013).
  • Cyranoski D . Stem cells boom in vet clinics. Nature496(7444) , 148–149 (2013).
  • Le Blanc K , FrassoniF, BallL et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a Phase II study. Lancet 371(9624) , 1579–1586 (2008).
  • Bouffi C , DjouadF, MathieuM, NoëlD, JorgensenC. Multipotent mesenchymal stromal cells and rheumatoid arthritis: risk or benefit? Rheumatology (Oxford)48(10) , 1185–1189 (2009).
  • Wakabayashi K , NagaiA, SheikhAM et al. Transplantation of human mesenchymal stem cells promotes functional improvement and increased expression of neurotrophic factors in a rat focal cerebral ischemia model. J. Neurosci. Res. 88(5) , 1017–1025 (2010).
  • Drela K , SiedleckaP, SarnowskaA, Domanska-JanikK. Human mesenchymal stem cells in the treatment of neurological diseases. Acta Neurobiol. Exp. (Wars.)73(1) , 38–56 (2013).
  • Musolino PL , CoronelMF, HökfeltT, VillarMJ. Bone marrow stromal cells induce changes in pain behavior after sciatic nerve constriction. Neurosci. Lett.418(1) , 97–101 (2007).
  • Abrams MB , DominguezC, PernoldK et al. Multipotent mesenchymal stromal cells attenuate chronic inflammation and injury-induced sensitivity to mechanical stimuli in experimental spinal cord injury. Restor. Neurol. Neurosci. 27(4) , 307–321 (2009).
  • Siniscalco D , GiordanoC, GalderisiU et al. Intra-brain microinjection of human mesenchymal stem cells decreases allodynia in neuropathic mice. Cell Mol. Life Sci. 67(4) , 655–669 (2010).
  • Siniscalco D , GiordanoC, GalderisiU et al. Long-lasting effects of human mesenchymal stem cell systemic administration on pain-like behaviors, cellular, and biomolecular modifications in neuropathic mice. Front. Integr. Neurosci. 5 , 79 (2011).
  • Guo W , WangH, ZouS et al. Bone marrow stromal cells produce long-term pain relief in rat models of persistent pain. Stem Cells 29(8) , 1294–1303 (2011).
  • Fortino VR , PelaezD, CheungHS. Concise review: stem cell therapies for neuropathic pain. Stem Cells Transl. Med.2(5) , 394–399 (2013).
  • Sacerdote P , NiadaS, FranchiS et al. Systemic administration of human adipose-derived stem cells reverts nociceptive hypersensitivity in an experimental model of neuropathy. Stem Cells Dev. 22(8) , 1252–1263 (2013).
  • Voswinkel J , FrancoisS, SimonJM et al. Use of mesenchymal stem cells (MSC) in chronic inflammatory fistulizing and fibrotic diseases: a comprehensive review. Clin. Rev. Allergy Immunol. 45(2) , 180–192 (2013).
  • Black LL , GaynorJ, GahringD et al. Effect of adipose-derived mesenchymal stem and regenerative cells on lameness in dogs with chronic osteoarthritis of the coxofemoral joints: a randomized, double-blinded, multicenter, controlled trial. Vet. Ther. 8(4) , 272–284 (2007).
  • Black LL , GaynorJ, AdamsC et al. Effect of intraarticular injection of autologous adipose-derived mesenchymal stem and regenerative cells on clinical signs of chronic osteoarthritis of the elbow joint in dogs. Vet. Ther. 9(3) , 192–200 (2008).
  • Liu Y , WuJ, ZhuY, HanJ. Therapeutic application of mesenchymal stem cells in bone and joint diseases. Clin. Exp. Med. doi:10.1007/s10238-012-0218-1 (2012) (Epub ahead of print).
  • Keerthi N , Chimutengwende-GordonM, SanghaniA, KhanW. The potential of stem cell therapy for osteoarthritis and rheumatoid arthritis. Curr. Stem Cell Res. Ther.8(6) , 444–450 (2013).
  • Pittenger MF , MackayAM, BeckSC et al. Multilineage potential of adult human mesenchymal stem cells. Science 284(5411) , 143–147 (1999).
  • Punwar S , KhanWS. Mesenchymal stem cells and articular cartilage repair: clinical studies and future direction. Open Orthop. J.5(Suppl. 2) , 296–301 (2011).
  • Koh YG , ChoiYJ. Infrapatellar fat pad-derived mesenchymal stem cell therapy for knee osteoarthritis. Knee19(6) , 902–907 (2012).
  • Koh YG , JoSB, KwonOR et al. Mesenchymal stem cell injections improve symptoms of knee osteoarthritis. Arthroscopy 29(4) , 748–755 (2013).
  • Pak J . Regeneration of human bones in hip osteonecrosis and human cartilage in knee osteoarthritis with autologous adipose tissue-derived stem cells: a case series. J. Med. Case Rep.5 , 296 (2011).
  • Ohgushi H , KotobukiN, FunaokaH et al. Tissue engineered ceramic artificial joint – ex vivo osteogenic differentiation of patient mesenchymal cells on total ankle joints for treatment of osteoarthritis. Biomaterials 26(22) , 4654–4661 (2005).
  • Centeno CJ , BusseD, KisidayJ, KeohanC, FreemanM, KarliD. Increased knee cartilage volume in degenerative joint disease using percutaneously implanted, autologous mesenchymal stem cells. Pain Physician11(3) , 343–353 (2008).
  • Davatchi F , AbdollahiBS, MohyeddinM, ShahramF, NikbinB. Mesenchymal stem cell therapy for knee osteoarthritis. Preliminary report of four patients. Int. J. Rheum. Dis.14(2) , 211–215 (2011).
  • Emadedin M , AghdamiN, TaghiyarL et al. Intra-articular injection of autologous mesenchymal stem cells in six patients with knee osteoarthritis. Arch. Iran Med. 15(7) , 422–428 (2012).
  • Ra JC , ShinIS, KimSH et al. Safety of intravenous infusion of human adipose tissue-derived mesenchymal stem cells in animals and humans. Stem Cells Dev. 20(8) , 1297–1308 (2011).
  • Lee KB , WangVT, ChanYH, HuiJH. A novel, minimally-invasive technique of cartilage repair in the human knee using arthroscopic microfracture and injections of mesenchymal stem cells and hyaluronic acid – a prospective comparative study on safety and short-term efficacy. Ann. Acad. Med. Singapore41(11) , 511–517 (2012).
  • Pak J . Autologous adipose tissue-derived stem cells induce persistent bone-like tissue in osteonecrotic femoral heads. Pain Physician15(1) , 75–85 (2012).
  • Liang J , LiX, ZhangH et al. Allogeneic mesenchymal stem cells transplantation in patients with refractory RA. Clin. Rheumatol. 31(1) , 157–161 (2012).
  • Ryu HH , KangBJ, ParkSS et al. Comparison of mesenchymal stem cells derived from fat, bone marrow, Wharton‘s jelly, and umbilical cord blood for treating spinal cord injuries in dogs. J. Vet. Med. Sci. 74(12) , 1617–1630 (2012).
  • Vacanti V , KongE, SuzukiG, SatoK, CantyJM, LeeT. Phenotypic changes of adult porcine mesenchymal stem cells induced by prolonged passaging in culture. J. Cell. Physiol.205(2) , 194–201 (2005).
  • Centeno CJ , SchultzJR, CheeverM et al. Safety and complications reporting update on the re-implantation of culture-expanded mesenchymal stem cells using autologous platelet lysate technique. Curr. Stem Cell Res. Ther. 6(4) , 368–378 (2011).
  • Peeters CM , LeijsMJ, ReijmanM, van Osch GJ, Bos PK. Safety of intra-articular cell-therapy with culture-expanded stem cells in humans: a systematic literature review. Osteoarthritis Cartilage21(10) , 1465–1473 (2013).
  • Le Blanc K , TammikC, RosendahlK, ZetterbergE, RingdénO. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp. Hematol.31(10) , 890–896 (2003).
  • Karia VR , CuchacovichR, EspinozaLR. Undifferentiated spondyloarthritis following allogeneic stem cell transplantation. BMC Musculoskelet. Disord.11 , 132 (2010).
  • Zimmerlin L , DonnenbergAD, RubinJP, BasseP, LandreneauRJ, DonnenbergVS. Regenerative therapy and cancer: in vitro and in vivo studies of the interaction between adipose-derived stem cells and breast cancer cells from clinical isolates. Tissue Eng. Part A.17(1–2) , 93–106 (2011).
  • Wakitani S , OkabeT, HoribeS et al. Safety of autologous bone marrow-derived mesenchymal stem cell transplantation for cartilage repair in 41 patients with 45 joints followed for up to 11 years and 5 months. J. Tissue Eng. Regen. Med. 5(2) , 146–150 (2011).
  • Tolar J , NautaAJ, OsbornMJ et al. Sarcoma derived from cultured mesenchymal stem cells. Stem Cells 25(2) , 371–379 (2007).
  • Jung JW , KwonM, ChoiJC et al. Familial occurrence of pulmonary embolism after intravenous, adipose tissue-derived stem cell therapy. Yonsei Med. J. 54(5) , 1293–1296 (2013).
  • Lee RH , PulinAA, SeoMJ et al. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell. 5(1) , 54–63 (2009).
  • Pluchino S , CossettiC. How stem cells speak with host immune cells in inflammatory brain diseases. Glia61(9) , 1379–1401 (2013).
  • Corder G , DoolenS, DonahueRR et al. Constitutive μ-opioid receptor activity leads to long-term endogenous analgesia and dependence. Science 341(6152) , 1394–1399 (2013).
  • Ren K , DubnerR. Descending control mechanisms. In: The Senses: A Comprehensive Reference. Basbaum AI, Kaneko A, Shepherd GM, Westheimer G, Bushnell MC, Basbaum AI (Eds). Academic Press, CA, USA, 723–762 (2008).
  • Imai S , GuoW, ZouS et al. The effect of bone marrow stromal cells on opioid receptor expression in pain modulatory circuitry in rats. Presented at: 42nd Annual Meeting of Society for Neuroscience. New Orleans, LA, USA, 13–17 October 2012.
  • Ren K , DubnerR. Interactions between the immune and nervous systems in pain. Nat. Med.16 , 1267–1276 (2010).
  • Augello A , TassoR, NegriniSM, CanceddaR, PennesiG. Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis. Arthritis Rheum.56(4) , 1175–1186 (2007).
  • Liu Y , MuR, WangS et al. Therapeutic potential of human umbilical cord mesenchymal stem cells in the treatment of rheumatoid arthritis. Arthritis Res. Ther. 12(6) , R210 (2010).
  • Nakajima H , UchidaK, GuerreroAR et al. Transplantation of mesenchymal stem cells promotes an alternative pathway of macrophage activation and functional recovery after spinal cord injury. J. Neurotrauma. 29(8) , 1614–1625 (2012).
  • Ma S , ZhongD, ChenH et al. The immunomodulatory effect of bone marrow stromal cells (BMSCs) on interleukin (IL)-23/IL-17-mediated ischemic stroke in mice. J. Neuroimmunol. 257(1–2) , 28–35 (2013).
  • Németh K , LeelahavanichkulA, YuenPS et al. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat. Med. 15(1) , 42–49 (2009).
  • Diekman BO , WuCL, LouerCR et al. Intra-articular delivery of purified mesenchymal stem cells from C57BL/6 or MRL/MpJ superhealer mice prevents posttraumatic arthritis. Cell Transplant. 22(8) , 1395–1408 (2013).
  • Djouad F , FritzV, ApparaillyF et al. Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collagen-induced arthritis. Arthritis Rheum. 52(5) , 1595–1603 (2005).
  • Papadopoulou A , YiangouM, AthanasiouE et al. Mesenchymal stem cells are conditionally therapeutic in preclinical models of rheumatoid arthritis. Ann. Rheum. Dis. 71(10) , 1733–1740 (2012).
  • Chen B , HuJ, LiaoL et al. Flk-1+ mesenchymal stem cells aggravate collagen-induced arthritis by up-regulating interleukin-6. Clin. Exp. Immunol. 159(3) , 292–302 (2010).
  • McGuckin CP , JurgaM, MillerAM et al. Ischemic brain injury: a consortium analysis of key factors involved in mesenchymal stem cell-mediated inflammatory reduction. Arch. Biochem. Biophys. 534(1–2) , 88–97 (2013).
  • Mokbel AN , El Tookhy OS, Shamaa AA, Rashed LA, Sabry D, El Sayed AM. Homing and reparative effect of intra-articular injection of autologus mesenchymal stem cells in osteoarthritic animal model. BMC Musculoskelet. Disord.12 , 259 (2011).
  • Kishk NA , GabrH, HamdyS et al. Case control series of intrathecal autologous bone marrow mesenchymal stem cell therapy for chronic spinal cord injury. Neurorehabil. Neural Repair. 24(8) , 702–708 (2010).
  • Franchi S , ValsecchiAE, BorsaniE et al. Intravenous neural stem cells abolish nociceptive hypersensitivity and trigger nerve regeneration in experimental neuropathy. Pain 153(4) , 850–861 (2012).
  • Hofstetter CP , HolmströmNA, LiljaJA et al. Allodynia limits the usefulness of intraspinal neural stem cell grafts; directed differentiation improves outcome. Nat. Neurosci. 8(3) , 346–353 (2005).
  • Harting MT , JimenezF, XueH et al. Intravenous mesenchymal stem cell therapy for traumatic brain injury. J. Neurosurg. 110(6) , 1189–1197 (2009).
  • Dayan V , YannarelliG, BilliaF et al. Mesenchymal stromal cells mediate a switch to alternatively activated monocytes/macrophages after acute myocardial infarction. Basic Res. Cardiol. 106(6) , 1299–1310 (2011).
  • Chen J , LiY, WangL, ZhangZ, LuD, LuM, ChoppM. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke32(4) , 1005–1011 (2001).
  • Bai L , LennonDP, EatonV et al. Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis. Glia 57(11) , 1192–1203 (2009).
  • Park BN , ShimW, LeeG et al. Early distribution of intravenously injected mesenchymal stem cells in rats with acute brain trauma evaluated by (99m)Tc-HMPAO labeling. Nucl. Med. Biol. 38(8) , 1175–1182 (2011).
  • Quertainmont R , CantinieauxD, BotmanO, SidS, SchoenenJ, FranzenR. Mesenchymal stem cell graft improves recovery after spinal cord injury in adult rats through neurotrophic and pro-angiogenic actions. PLoS ONE7(6) , e39500 (2012).
  • Mitkari B , KerkeläE, NystedtJ et al. Intra-arterial infusion of human bone marrow-derived mesenchymal stem cellsresults in transient localization in the brain after cerebral ischemia in rats. Exp. Neurol. 239 , 158–162 (2013).
  • Karp JM , Leng Teo GS. Mesenchymal stem cell homing: the devil is in the details. Cell Stem Cell.4(3) , 206–216 (2009).
  • Wood JA , ChungDJ, ParkSA et al. Periocular and intra-articular injection of canine adipose-derived mesenchymal stem cells: an in vivo imaging and migration study. J. Ocul. Pharmacol. Ther. 28(3) , 307–317 (2012).
  • Li Y , ChenJ, ZhangCL et al. Gliosis and brain remodeling after treatment of stroke in rats with marrow stromal cells. Glia 49(3) , 407–417 (2005).
  • Brack A , LabuzD, SchiltzA et al. Tissue monocytes/macrophages in inflammation: hyperalgesia versus opioid-mediated peripheral antinociception. Anesthesiology 101(1) , 204–211 (2004).
  • Lawrence T , NatoliG. Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat. Rev. Immunol.11(11) , 750–761 (2011).
  • Zhang QZ , SuWR, ShiSH et al. Human gingiva-derived mesenchymal stem cells elicit polarization of m2 macrophages and enhance cutaneous wound healing. Stem Cells 28(10) , 1856–1868 (2010).
  • Walker PA , ShahSK, JimenezF et al. Bone marrow-derived stromal cell therapy for traumatic brain injury is neuroprotective via stimulation of non-neurologic organ systems. Surgery 152(5) , 790–793 (2012).
  • Romieu-Mourez R , FrançoisM, BoivinMN, BouchentoufM, SpanerDE, GalipeauJ. Cytokine modulation of TLR expression and activation in mesenchymal stromal cells leads to a proinflammatory phenotype. J. Immunol.182(12) , 7963–7973 (2009).
  • Waterman RS , TomchuckSL, HenkleSL, BetancourtAM. A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an immunosuppressive MSC2 phenotype. PLoS ONE5 , e10088 (2010).
  • Waterman RS , MorgenweckJ, NossamanBD, ScandurroAE, ScandurroSA, BetancourtAM. Anti-inflammatory mesenchymal stem cells (MSC2) attenuate symptoms of painful diabetic peripheral neuropathy. Stem Cells Transl. Med.1(7) , 557–565 (2012).
  • Digirolamo CM , StokesD, ColterD et al. Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate. Br. J. Haematol. 107 , 275–281 (1999).
  • Rombouts WJ , PloemacherRE. Primary murine MSC show highly efficient homing to the bone marrow but lose homing ability following culture. Leukemia17(1) , 160–170 (2003).
  • Izadpanah R , KaushalD, KriedtC et al. Long-term in vitro expansion alters the biology of adult mesenchymal stem cells. Cancer Res. 68(11) , 4229–4238 (2008).
  • Briquet A , DuboisS, BekaertS, DolhetM, BeguinY, GothotA. Prolonged ex vivo culture of human bone marrow mesenchymal stem cells influences their supportive activity toward NOD/SCID-repopulating cells and committed progenitor cells of B lymphoid and myeloid lineages. Haematologica95(1) , 47–56 (2010).
  • Honczarenko M , LeY, SwierkowskiM, GhiranI, GlodekAM, SilbersteinLE. Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors. Stem Cells24(4) , 1030–1041 (2006).
  • Tao F , LiQ, LiuS et al. Role of neuregulin-1/ErbB signaling in stem cell therapy for spinal cord injury-induced chronic neuropathic pain. Stem Cells 31(1) , 83–91 (2013).
  • He S , KhanJ, GleasonJ et al. Placenta-derived adherent cells attenuate hyperalgesia and neuroinflammatory response associated with perineural inflammation in rats. Brain Behav. Immun. 27(1) , 185–192 (2013).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.